BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 32831113)

  • 21. Carbon ion radiotherapy for sacral chordoma.
    Imai R; Kamada T; Sugahara S; Tsuji H; Tsujii H
    Br J Radiol; 2011 Dec; 84 Spec No 1(Spec Iss 1):S48-54. PubMed ID: 21427182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma.
    El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
    Radiat Oncol; 2018 May; 13(1):86. PubMed ID: 29739417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sacral chordoma: a clinical review of 101 cases with 30-year experience in a single institution.
    van Wulfften Palthe ODR; Tromp I; Ferreira A; Fiore A; Bramer JAM; van Dijk NC; DeLaney TF; Schwab JH; Hornicek FJ
    Spine J; 2019 May; 19(5):869-879. PubMed ID: 30445184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report.
    Ares C; Hug EB; Lomax AJ; Bolsi A; Timmermann B; Rutz HP; Schuller JC; Pedroni E; Goitein G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1111-8. PubMed ID: 19386442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of Residual Tumor Volume and Radiation Dose Coverage in Outcomes for Clival Chordoma.
    McDonald MW; Linton OR; Moore MG; Ting JY; Cohen-Gadol AA; Shah MV
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):304-311. PubMed ID: 26519991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
    Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
    Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensity-modulated radiotherapy of sacral chordoma--a case report and a comparison with stereotactic conformal radiotherapy.
    Thilmann C; Schulz-Ertner D; Zabel A; Herfarth KK; Wannenmacher M; Debus J
    Acta Oncol; 2002; 41(4):395-9. PubMed ID: 12234033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcomes of high dose carbon-ion radiation therapy for unresectable upper cervical (C1-2) chordoma.
    Aoki S; Koto M; Ikawa H; Imai R; Tokuhiko O; Shinoto M; Takiyama H; Yamada S; Tsuji H
    Head Neck; 2022 Oct; 44(10):2162-2170. PubMed ID: 35734902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
    Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
    Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High control rates of proton- and carbon-ion-beam treatment with intensity-modulated active raster scanning in 101 patients with skull base chondrosarcoma at the Heidelberg Ion Beam Therapy Center.
    Mattke M; Vogt K; Bougatf N; Welzel T; Oelmann-Avendano J; Hauswald H; Jensen A; Ellerbrock M; Jäkel O; Haberer T; Herfarth K; Debus J; Uhl M
    Cancer; 2018 May; 124(9):2036-2044. PubMed ID: 29469932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maximum surgical resection and adjuvant intensity-modulated radiotherapy with simultaneous integrated boost for skull base chordoma.
    Kim JW; Suh CO; Hong CK; Kim EH; Lee IJ; Cho J; Lee KS
    Acta Neurochir (Wien); 2017 Oct; 159(10):1825-1834. PubMed ID: 27502775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active raster scanning with carbon ions: reirradiation in patients with recurrent skull base chordomas and chondrosarcomas.
    Uhl M; Welzel T; Oelmann J; Habl G; Hauswald H; Jensen A; Ellerbrock M; Debus J; Herfarth K
    Strahlenther Onkol; 2014 Jul; 190(7):686-91. PubMed ID: 24663287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of radiotherapy on survival after surgical resection of chordoma with minimum five-year follow-up.
    Tobert DG; Kelly SP; Xiong GX; Chen YL; MacDonald SM; Bongers ME; Lozano-Calderon SA; Newman ET; Raskin KA; Schwab JH
    Spine J; 2023 Jan; 23(1):34-41. PubMed ID: 35470086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definitive high-dose photon/proton radiotherapy for unresected mobile spine and sacral chordomas.
    Chen YL; Liebsch N; Kobayashi W; Goldberg S; Kirsch D; Calkins G; Childs S; Schwab J; Hornicek F; DeLaney T
    Spine (Phila Pa 1976); 2013 Jul; 38(15):E930-6. PubMed ID: 23609202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor.
    Park L; Delaney TF; Liebsch NJ; Hornicek FJ; Goldberg S; Mankin H; Rosenberg AE; Rosenthal DI; Suit HD
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1514-21. PubMed ID: 16757128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure.
    Noël G; Habrand JL; Jauffret E; de Crevoisier R; Dederke S; Mammar H; Haie-Méder C; Pontvert D; Hasboun D; Ferrand R; Boisserie G; Beaudré A; Gaboriaud G; Guedea F; Petriz L; Mazeron JJ
    Strahlenther Onkol; 2003 Apr; 179(4):241-8. PubMed ID: 12707713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Phase 1 Study of Nilotinib Plus Radiation in High-Risk Chordoma.
    Cote GM; Barysauskas CM; DeLaney TF; Schwab J; Raskin K; Lozano-Calderon S; Bernstein K; Mullen JT; Haynes AB; Hornicek F; Chen YE; Choy E
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1496-1504. PubMed ID: 30077789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience.
    Weber DC; Rutz HP; Pedroni ES; Bolsi A; Timmermann B; Verwey J; Lomax AJ; Goitein G
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):401-9. PubMed ID: 16168833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials.
    Imai R; Kamada T; Tsuji H; Sugawara S; Serizawa I; Tsujii H; Tatezaki S;
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1470-6. PubMed ID: 19939576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas.
    Schulz-Ertner D; Karger CP; Feuerhake A; Nikoghosyan A; Combs SE; Jäkel O; Edler L; Scholz M; Debus J
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):449-57. PubMed ID: 17363188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.